FR2886852B1 - Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee - Google Patents

Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee

Info

Publication number
FR2886852B1
FR2886852B1 FR0505919A FR0505919A FR2886852B1 FR 2886852 B1 FR2886852 B1 FR 2886852B1 FR 0505919 A FR0505919 A FR 0505919A FR 0505919 A FR0505919 A FR 0505919A FR 2886852 B1 FR2886852 B1 FR 2886852B1
Authority
FR
France
Prior art keywords
avermectin
rosacea
hydrocortisone
treatment
composition based
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0505919A
Other languages
English (en)
Other versions
FR2886852A1 (fr
Inventor
Alexandre Kaoukhov
Colette Pernin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0505919A priority Critical patent/FR2886852B1/fr
Application filed by Galderma SA filed Critical Galderma SA
Priority to EP06764751A priority patent/EP1898932A2/fr
Priority to PCT/FR2006/001299 priority patent/WO2006131651A2/fr
Priority to CA002610761A priority patent/CA2610761A1/fr
Priority to BRPI0612935-8A priority patent/BRPI0612935A2/pt
Publication of FR2886852A1 publication Critical patent/FR2886852A1/fr
Application granted granted Critical
Publication of FR2886852B1 publication Critical patent/FR2886852B1/fr
Priority to US12/000,186 priority patent/US20080176928A1/en
Priority to US12/394,217 priority patent/US20090163455A1/en
Priority to US12/843,372 priority patent/US20110178049A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0505919A 2005-06-10 2005-06-10 Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee Expired - Fee Related FR2886852B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0505919A FR2886852B1 (fr) 2005-06-10 2005-06-10 Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee
PCT/FR2006/001299 WO2006131651A2 (fr) 2005-06-10 2006-06-08 Composition a base d'une avermectine et d’ηydrocortisone notamment pour le traitement de la rosacée
CA002610761A CA2610761A1 (fr) 2005-06-10 2006-06-08 Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee
BRPI0612935-8A BRPI0612935A2 (pt) 2005-06-10 2006-06-08 composição farmacêutica e uso
EP06764751A EP1898932A2 (fr) 2005-06-10 2006-06-08 Composition a base d'une avermectine et d ydrocortisone notamment pour le traitement de la rosacée
US12/000,186 US20080176928A1 (en) 2005-06-10 2007-12-10 Avermectin/hydrocortisone compositions for treating afflictions of the skin, E.G., rosacea
US12/394,217 US20090163455A1 (en) 2005-06-10 2009-02-27 Avermectin/hydrocortisone compositions for treating afflictions of the skin, e.g., rosacea
US12/843,372 US20110178049A1 (en) 2005-06-10 2010-07-26 Avermectin/hydrocortisone compositions for treating afflictions of the skin. e.g., rosacea

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0505919A FR2886852B1 (fr) 2005-06-10 2005-06-10 Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee

Publications (2)

Publication Number Publication Date
FR2886852A1 FR2886852A1 (fr) 2006-12-15
FR2886852B1 true FR2886852B1 (fr) 2007-11-23

Family

ID=35169321

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0505919A Expired - Fee Related FR2886852B1 (fr) 2005-06-10 2005-06-10 Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee

Country Status (6)

Country Link
US (3) US20080176928A1 (fr)
EP (1) EP1898932A2 (fr)
BR (1) BRPI0612935A2 (fr)
CA (1) CA2610761A1 (fr)
FR (1) FR2886852B1 (fr)
WO (1) WO2006131651A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010085753A1 (fr) * 2009-01-23 2010-07-29 Jr Chem, Llc Traitements pour l'acné rosacée et trousses médicales pour les mettre en pratique
FR2942138A1 (fr) 2009-02-16 2010-08-20 Galderma Res & Dev Association de composes pour le traitement ou la prevention des affections dermatologiques
FR3000397A1 (fr) * 2012-12-31 2014-07-04 Galderma Res & Dev Combinaison de laropiprant et d'ivermectine pour le traitement de la rosacee
US9782425B2 (en) 2013-07-08 2017-10-10 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
US9233118B2 (en) 2013-07-08 2016-01-12 Galderma S.A. Treatment of papulopustular rosacea with ivermectin
WO2016096795A1 (fr) * 2014-12-15 2016-06-23 Galderma Sa Composé de la famille des avermectines utilisable en vue du traitement et/ou de la prévention de dermatoses inflammatoires
WO2016096797A1 (fr) * 2014-12-15 2016-06-23 Galderma Sa Composé de la famille des avermectines associé à un autre composé actif en vue du traitement et/ou de la prévention des dermatoses inflammatoires

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265511A (en) * 1963-06-12 1966-08-09 Honeywell Inc Electroless plating
US3265571A (en) * 1965-04-08 1966-08-09 Barnes Hind Pharm Inc Thixotropic acne vulgaris composition
US5952372A (en) * 1998-09-17 1999-09-14 Mcdaniel; William Robert Method for treating rosacea using oral or topical ivermectin
US6399652B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating acne vulgaris using avermectin compound
MXPA05011208A (es) * 2003-04-24 2005-12-14 Galderma Sa Uso de ivermectina para el tratamiento de desordenes dermatologicos.

Also Published As

Publication number Publication date
US20110178049A1 (en) 2011-07-21
WO2006131651A3 (fr) 2007-09-13
US20080176928A1 (en) 2008-07-24
BRPI0612935A2 (pt) 2010-12-07
CA2610761A1 (fr) 2006-12-14
US20090163455A1 (en) 2009-06-25
FR2886852A1 (fr) 2006-12-15
WO2006131651A2 (fr) 2006-12-14
EP1898932A2 (fr) 2008-03-19

Similar Documents

Publication Publication Date Title
FR2886851B1 (fr) Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee
GB2414933B (en) Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis
DK2155758T3 (da) Tetrahydrofuro[3,4-d]dioxolanforbindelser til anvendelse i behandlingen af virusinfektioner og cancer
CR8642A (es) Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos
FR2908042B1 (fr) Ensemble d'intubation monocanaliculonasal et/ou monocanaliculaire,notamment pour l'imperforation lacrymonasale.
CL2007001132A1 (es) Compuestos derivados de purina sustituida con otros sistemas heterociclicos; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de una enfermedad inflamatoria u obstructiva de las vias respiratorias.
IL183963A0 (en) 1 - aminocyclohexane - derivatives for the treatment of multiple sclerosis, emotional liability and pseudobulbar affect
CL2007003444A1 (es) Compuestos derivados de pirrolo[3,2-c]piridina; composicion farmaceutica; y uso en el tratamiento de un trastorno hiperproliferativo o una enfermedad inflamatoria.
FR2886852B1 (fr) Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee
FR2886850B1 (fr) Composition a base d'une avermectine et de peroxyde de benzoyle notamment pour le traitement de la rosacee
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
EP1978034A4 (fr) Anticorps anti-periostine et composition pharmaceutique pour prevenir ou traiter une maladie liee a la periostine contenant cet anticorps
CL2007003038A1 (es) Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos.
FR2873691B1 (fr) Derives d'amino-piperidine, leur preparation et leur application en therapeutique
WO2007059226A3 (fr) Agents antimicrobiens photoactivatables
CL2007003672A1 (es) Compuestos derivados de heteroaril-pirrolidinil-cetona y heteroaril-piperidinil-cetona; composicion farmaceutica; y uso en el tratamiento de la depresion y ansiedad.
MA28844B1 (fr) Composition pharmaceutique comprenant de la drospirenone et de l'ethynylestradiol
FR2883181B1 (fr) Composition a base d'une avermectine et d'acide azelaique notamment pour le traitement de la rosacee
CL2007000789A1 (es) Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer.
DK1838716T3 (da) Olanzapinpamota-dihydrat
HK1097762A1 (en) Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients
BRPI0614481A2 (pt) composto, composição farmecêutica, uso do composto, e, método de tratamento de distúrbios mediados por mglur5
ITRM20050478A1 (it) Apparato per l'applicazione contemporanea della carbossiterapia e della mesoterapia.
ITRM20040223A1 (it) Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi.
FR2887456B1 (fr) "composition pour le traitement de la dermite estivale"

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20140228